Study of causes and progression of low CD4 blood cells
Part of Blood & lymphatic, Brain & nervous system, Immune system & allergy, Infections, Skin clinical trials.
This study looks for what causes and how idiopathic low CD4 cells happen over time, using blood and tissue samples. It may help doctors learn why this occurs and how to better track people with it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your CD4 count is low on at least two blood tests, 6 weeks apart, or CD4 is under 20%
- You have a primary care clinician who is actively following your care
- You are willing to let the study store your blood and tissue samples for future testing
- You do not have known HIV or HTLV infection, or another known immune disorder besides ICL
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood-forming cells from people with low CD4 counts and healthy volunteers to learn how the immune system works. It may help researchers better understand and treat conditions like idiopathic CD4 lymphocytopenia.
This Phase 1/2 study tests a long-acting IL-7 medicine to raise low CD4 immune cells in people with idiopathic CD4 lymphopenia. Because this is a dose-escalation study, the goal is to check safety and see if the treatment affects immune cell levels.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This Phase 1 study tests how safe belimumab is for people with idiopathic CD4 lymphopenia (low protective white blood cells) and signs of autoantibodies. It aims to learn whether the treatment is tolerable and could be a future option for people with this immune condition.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
This study looks at how the immune system works in people who have abnormal immune function, often shown by unusual or repeated infections or long-lasting inflammation. It may involve tests using blood samples and storage of blood for future research.
Hear when a new Cryptococcal Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.